세계의 에소테릭 검사(특수 검사) 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Esoteric Testing Market is presumed to reach the market size of nearly USD 33.28 Billion by 2032 from USD 26.96 Billion in 2023 with a CAGR of 2.37% under the study period 2024-2032.

Esoteric testing refers to specialized, advanced diagnostic tests not routinely performed in standard clinical laboratories. These tests often require sophisticated technology and expertise due to their complexity. They are typically used to diagnose rare diseases, identify specific genetic disorders, or detect biomarkers for complex conditions. Examples of esoteric tests include molecular diagnostics, specialized immunoassays, and advanced microbiological cultures. This testing is crucial for personalized medicine, enabling tailored treatment plans based on precise diagnostic information. These tests provide critical insights into complex medical cases where conventional testing methods may not be sufficient, thereby improving patient outcomes through targeted therapies.

MARKET DYNAMICS

The esoteric testing market is primarily fuelled by the increasing demand for specialized tests that provide detailed insights into complex medical conditions. Advances in biotechnology and molecular diagnostics have expanded the range of esoteric tests available, allowing for more precise and comprehensive analysis of diseases at a genetic and molecular level. This is particularly important for the early detection and personalized treatment of rare and complex diseases, which conventional tests may not adequately address. The spurring prevalence of chronic & genetic disorders further fuels the demand for esoteric testing. Additionally, rising healthcare expenditure and the emphasis on preventive care and early diagnosis contribute to market growth. The expanding healthcare infrastructure & the increasing number of specialized laboratories also drive the adoption of esoteric testing. Furthermore, collaborations between healthcare providers, diagnostic companies, and research institutions enhance the development and accessibility of esoteric tests. However, high costs and the need for specialized expertise may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Esoteric Testing. The growth and trends of Esoteric Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Esoteric Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Oncology Testing
• Infectious Disease Testing
• Genetic Testing
• Endocrinology Testing
• Toxicology Testing
• Neurology Testing
• Others

By Technology

• Chemiluminescence Immunoassay
• Enzyme-Linked Immunosorbent Assay
• Mass Spectrometry
• Real Time Polymerase Chain Reaction
• Flow Cytometry
• Other

By End-use

• Hospital-Based Laboratories
• Independent And Reference Laboratories
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Esoteric Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Esoteric Testing market include Laboratory Corporation Of America Holdings, OPKO Health Inc., Quest Diagnostics Incorporated, Sonic Healthcare Limited, H.U. Group Holdings Inc. Kindstar Globalgene Technology Inc., Stanford Health Care, Mayo Foundation For Medical Education And Research, ARUP Laboratories, Athena Esoterix, ACM Global Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. ESOTERIC TESTING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ESOTERIC TESTING MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. Oncology Testing Historic and Forecast Sales By Regions
• 5.4. Infectious Disease Testing Historic and Forecast Sales By Regions
• 5.5. Genetic Testing Historic and Forecast Sales By Regions
• 5.6. Endocrinology Testing Historic and Forecast Sales By Regions
• 5.7. Toxicology Testing Historic and Forecast Sales By Regions
• 5.8. Neurology Testing Historic and Forecast Sales By Regions
• 5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL ESOTERIC TESTING MARKET ANALYSIS BY TECHNOLOGY

• 6.1. Overview By Technology
• 6.2. Historical and Forecast Data Analysis By Technology
• 6.3. Chemiluminescence Immunoassay Historic and Forecast Sales By Regions
• 6.4. Enzyme-Linked Immunosorbent Assay Historic and Forecast Sales By Regions
• 6.5. Mass Spectrometry Historic and Forecast Sales By Regions
• 6.6. Real Time Polymerase Chain Reaction Historic and Forecast Sales By Regions
• 6.7. Flow Cytometry Historic and Forecast Sales By Regions
• 6.8. Other Historic and Forecast Sales By Regions

7. GLOBAL ESOTERIC TESTING MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-use
• 7.2. Historical and Forecast Data Analysis By End-use
• 7.3. Hospital-Based Laboratories Historic and Forecast Sales By Regions
• 7.4. Independent And Reference Laboratories Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL ESOTERIC TESTING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ESOTERIC TESTING COMPANIES

• 9.1. Esoteric Testing Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF ESOTERIC TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Laboratory Corporation Of America Holdings
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. OPKO Health Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Quest Diagnostics Incorporated
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Sonic Healthcare Limited
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. H.U. Group Holdings Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Stanford Health Care
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Mayo Foundation For Medical Education And Research
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. ARUP Laboratories
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Athena Esoterix
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. ACM Global Laboratories
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Kindstar Globalgene Technology Inc.
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies